profit from every $100 of sales.
$0$100
HCM III Acquisition
$10.44+0.00% today
-0.3% in 1 year
1-year low $10.211-year high $10.52
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
HCM III Acquisition vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| HCM III Acquisition | No profit yet | ||
 Churchill Capital Corp X | No profit yet | ||
 Drugs Made In America Acquisition II | 155.8× · No profit yet | ||
 Bain Capital GSS Investment Cor | No profit yet | ||
 Cantor Equity Partners IV | 96.3× · No profit yet |
AI analysis
An AI analyst reads HCM III Acquisition's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- –
- –
- –
- -13,199.7×
- 0.0×
- –
- –
- -0.4%
- -0.0%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -33.8%
- -1.0%
- 307.3%
- -16.6%
- -33.8%
- –
Growth
- –
- –
- −8,153.2%
- –
- −31.0%
Financial health
- -3.3×
- -10.10
- 54.5%
- –
- 0.09
- 0.09
- 0.00
How it ranks in Financial Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 1%of 848
Bottom 6%of 728
Bottom 17%of 932
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Sep 30, 2023 | -0.07 | – | – |
| Jun 30, 2023 | 0.07 | – | – |
| Mar 31, 2023 | 0.33 | – | – |
| Dec 31, 2022 | 15,058,830.00 | – | – |
News
Inve outlines $30M SaaS acquisition plan supported by Trackonomy partnershipSeeking Alpha · Nov 12, 2026Broadwind targets net leverage below 2.0x following MCM acquisitionSeeking Alpha · Nov 12, 2026York Space Systems plans acquisition of Outlook Industries to expand into unmanned systemsSeeking Alpha · Nov 12, 2026Onterris expands Permian Basin presence with PBELab acquisitionSeeking Alpha · Nov 9, 2026Elon Musk opens the door for a big SpaceX acquisitionMarketWatch · Nov 6, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/6Passes 0 of 6. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
25No pass
Benjamin Graham
0No pass
Philip Fisher
36No pass
Peter Lynch
–Not enough data
Joel Greenblatt
0No pass
Charlie Munger
25No pass
Terry Smith
21No pass
Questions about HCM III Acquisition
Is HCM III Acquisition a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 6 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the HCM III Acquisition AI analysis
What does HCM III Acquisition do?
HCM Acquisition Corp does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It is in Shell Companies.
Does HCM III Acquisition pay a dividend?
No. HCM III Acquisition does not pay a dividend at the moment.
Is HCM III Acquisition stock halal?
Questionable. HCM III Acquisition sits in a grey zone: scholars disagree about its industry. How we check
How has HCM III Acquisition stock done over the past year?
Down 0.3% over the past twelve months, to $10.44. It traded between $10.21 and $10.52, close to its high.
Who are HCM III Acquisition's competitors?
The largest listed companies in the same industry are Churchill Capital Corp X, Drugs Made In America Acquisition II, Bain Capital GSS Investment Cor and Cantor Equity Partners IV. The peers table on this page compares their profit, growth and price with HCM III Acquisition's.
Prices: daily closes to Nov 6, 2026. Fundamentals: company reports via invest-like data.